Fuji Pharma Company Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fuji Pharma Company Limited with three other
companies in this sector in JAPAN :
JCR Pharmaceuticals Co., Ltd.
sales of 23.16 billion Japanese Yen [US$218.63 million]
of which 99%
was Pharmaceutical Business),
Daito Pharmaceutical Company Limited
(41.13 billion Japanese Yen [US$388.31 million]
of which 54%
was Drug Substance), and
Koa Shoji Holdings Co Ltd
(15.21 billion Japanese Yen [US$143.54 million]
of which 72%
was Drug substance sales business).
Fuji Pharma Company Limited reported sales of ¥36.28 billion (US$342.47 million)
September of 2019.
decrease of 4.3%
versus 2018, when the company's sales were ¥37.91 billion.